Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer by Rochester, M, Riedemann, J, Hellawell, G, Brewster, S, Macaulay, V

Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer. by Rochester, M, Riedemann, J, Hellawell, G, Brewster, S, Macaulay, V

Down regulating Delta-4 (DLL4) using RNA interference - a potential future treatment for bladder cancer by Patel, N, Dobby, M, Li, J, Rochester, M, Cranston, D, Harris, A

The type 1 insulin-like growth factor receptor is over-expressed in bladder cancer. by Rochester, M, Patel, N, Turney, B, Davies, DR, Roberts, I, Crew, J, Protheroe, A, Macaulay, V

Depletion of the type 1 IGF receptor delays repair of radiation-induced DNA double strand breaks by Turney, B, Kerr, M, Chitnis, M, Lodhia, K, Wang, Y, Riedemann, J, Rochester, M, Protheroe, A, Brewster, S, Macaulay, V

Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer. by Patel, N, Dobbie, MS, Rochester, M, Steers, G, Poulsom, R, Le Monnier, K, Cranston, D, Li, J, Harris, A